HIV-related non-Hodgkin's lymphoma among European AIDS patients. AIDS in Europe Study Group. AIDS in Europe Study Group. 1995

C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
Department of Infectious Disease, State University Hospital, Copenhagen, Denmark.

The epidemiology of HIV associated non-Hodgkin's lymphoma (NHL) was investigated in 6550 European patients with AIDS. NHL was diagnosed in 3.5% of all patients at the time of the AIDS diagnosis. Although the probability of being diagnosed with NHL at AIDS diagnosis was significantly higher among intravenous drug users than among homosexual men, and was associated with increasing age, the observed incidences of NHL were more strikingly similar than any differences. The rate of developing NHL after a previous AIDS diagnosis was 2.4 per 100 patient years of follow-up, and remained constant during a 5-year follow-up period. While primary brain lymphomas comprised only 9% of NHL diagnosed at the time of AIDS, they comprised 38% of NHL diagnosed after AIDS (p < 0.001). The prognosis for patients with NHL at AIDS diagnosis was poor with a median survival of 5 months. A diagnosis of primary brain lymphoma was uniformly associated with a poor outcome. It is concluded that the probability of developing NHL in late stage HIV infection is lower than previously anticipated from the results of small studies on patients receiving long-term anti-retroviral therapy.

UI MeSH Term Description Entries
D008297 Male Males
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D005060 Europe The continent north of AFRICA, west of ASIA and east of the ATLANTIC OCEAN. Northern Europe,Southern Europe,Western Europe
D005260 Female Females
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012727 Sex Characteristics Those characteristics that distinguish one SEX from the other. The primary sex characteristics are the OVARIES and TESTES and their related hormones. Secondary sex characteristics are those which are masculine or feminine but not directly related to reproduction. Gender Characteristics,Gender Differences,Gender Dimorphism,Sex Differences,Sex Dimorphism,Sexual Dichromatism,Sexual Dimorphism,Characteristic, Gender,Characteristic, Sex,Dichromatism, Sexual,Dichromatisms, Sexual,Difference, Sex,Dimorphism, Gender,Dimorphism, Sex,Dimorphism, Sexual,Gender Characteristic,Gender Difference,Gender Dimorphisms,Sex Characteristic,Sex Difference,Sex Dimorphisms,Sexual Dichromatisms,Sexual Dimorphisms

Related Publications

C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
January 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
October 2000, Sexually transmitted infections,
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
May 2002, European journal of internal medicine,
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
July 1991, Oncology nursing forum,
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
November 1997, International journal of cancer,
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
April 2003, AIDS (London, England),
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
March 1996, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
May 1993, AJR. American journal of roentgenology,
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
February 1998, The American surgeon,
C Pedersen, and S E Barton, and A Chiesi, and P Skinhøj, and C Katlama, and A Johnson, and J van Lunzen, and B Hirschel, and S Maayan, and J D Lundgren
January 1996, Pathology oncology research : POR,
Copied contents to your clipboard!